Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Does a high triglyceride and low HDL cholesterol pattern indicate insulin resistance and increased cardiometabolic risk even with normal HbA1c?

A high triglycerides/low HDL cholesterol pattern is associated with insulin resistance and elevated cardiometabolic risk even when HbA1c is normal.

SupportedJune 19, 202618 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

A triglycerides-high and HDL cholesterol-low lipid pattern is associated with insulin resistance and increased cardiometabolic risk even when HbA1c is normal.

laying out figure…
All 1 path supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that a TG‑high/HDL‑low lipid profile reliably marks underlying insulin resistance and predicts greater cardiovascular and metabolic risk despite normal average glucose. Mechanistically, impaired suppression of adipose lipolysis and increased hepatic VLDL production raise triglycerides while altered lipoprotein exchange and clearance lower HDL, creating residual atherogenic risk not captured by HbA1c alone.

Verified conclusion

The interaction between lipid profiles and metabolic health is a critical area of cardiovascular research, particularly when traditional markers like HbA1c appear within normal ranges. Research consistently demonstrates that the relationship between high triglycerides (TG) and low high-density lipoprotein cholesterol (HDL-C) is a potent indicator of underlying metabolic dysfunction.

Clinical evidence and cardiometabolic risk

Large-scale cohort studies and systematic reviews confirm that a high TG/HDL-C ratio is a strong surrogate marker for insulin resistance (IR), often showing a correlation with the HOMA-IR index as high as 0.955. This lipid pattern is significantly associated with increased cardiometabolic risk even in individuals with normal HbA1c levels.

  • Predictive Value: In normoglycemic populations, elevated TG/HDL-C ratios are associated with Hazard Ratios for Major Adverse Cardiovascular Events (MACE) ranging from 1.10 to 2.85.
  • Sensitivity: The ratio has demonstrated high diagnostic accuracy for identifying metabolic syndrome in those with normal glucose, with an Area Under the Curve (AUC) reaching 0.896.
  • Clinical Cutoffs: Research suggests specific thresholds, such as ratios >2.8 for men and >2.5 for women, as reliable markers for detecting insulin resistance.

Mechanistic explanations

The association is driven by integrated physiological pathways that link lipid metabolism directly to insulin sensitivity:

  • Adipose Tissue Dysregulation: In an insulin-resistant state, the body fails to suppress lipolysis effectively. This results in an influx of free fatty acids (FFAs) into the liver, which stimulates de novo lipogenesis and the overproduction of Very Low-Density Lipoproteins (VLDL), directly raising triglyceride levels.
  • HDL Clearance: Insulin resistance impairs the activity of lipoprotein lipase and increases the activity of Cholesteryl Ester Transfer Protein (CETP). CETP facilitates the exchange of triglycerides into HDL particles; these TG-enriched HDL particles are rapidly cleared from circulation, leading to the characteristic low HDL-C levels.
  • Residual Risk: This pattern often signifies the presence of atherogenic remnant lipoproteins and systemic inflammation, factors that drive vascular damage even when blood glucose averages remain within healthy limits.

Bottom line

A high TG/low HDL pattern is a robustly supported biomarker for insulin resistance and elevated cardiovascular risk. It provides critical prognostic information that HbA1c may overlook, identifying subclinical metabolic dysfunction and residual risk in otherwise "healthy" normoglycemic individuals.

References

  1. The Triglyceride/HDL Ratio as a Surrogate Biomarker for Insulin Resistance — mdpi.com ↗
  2. Can We Use the Triglyceride/HDL Ratio to Determine Insulin Resistance in Obesity Screening and Follow-Up in Primary Care? — jag.journalagent.com ↗
  3. Can Triglycerides-HDL-C Ratio, HOMA-IR, ApoB, Non-HDL Cholesterol, and Free Cholesterol be Laboratory-Associated Flags of Female Coronary Atherosclerosis Regardless of Being Diabetic? — openbiomarkerjournal.com ↗
  4. Insulin Resistance Markers to Detect Nonalcoholic Fatty Liver Disease in a Male Hispanic Population — hindawi.com ↗
  5. RANK/RANKL/OPG pathway is an important for the epigenetic regulation of obesity — link.springer.com ↗
  6. TG: HDL-C Ratio as Insulin Resistance Marker for Metabolic Syndrome in Children With Obesity — frontiersin.org ↗
  7. Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina — pmc.ncbi.nlm.nih.gov ↗
  8. Targeting Low HDL-Cholesterol to Decrease Residual Cardiovascular Risk in the Managed Care Setting — jmcp.org ↗
  9. The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease — pmc.ncbi.nlm.nih.gov ↗
  10. Elevated triglycerides are related to higher residual cardiovascular disease and mortality risk independent of lipid targets and intensity of lipid-lowering therapy in patients with established cardiovascular disease. — linkinghub.elsevier.com ↗
  11. Elevated triglycerides are related to higher residual cardiovascular disease and mortality risk independent of lipid targets and lipid-lowering therapy intensity in cardiovascular disease patients — academic.oup.com ↗
  12. Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study — pmc.ncbi.nlm.nih.gov ↗
  13. Biochemical and Anthropometric Indices of Insulin Resistance in Obese and Overweight Children with Metabolic Dysfunction-Associated Fatty Liver Disease — medscimonit.com ↗
  14. The Triglyceride/HDL Ratio as a Surrogate Biomarker for Insulin Resistance — pmc.ncbi.nlm.nih.gov ↗
  15. Assessing the Relationship between Systemic Immune-Inflammation Index and Metabolic Syndrome in Children with Obesity — mdpi.com ↗
  16. Triglyceride-glucose-body mass index and the incidence of cardiovascular diseases: a meta-analysis of cohort studies — cardiab.biomedcentral.com ↗
  17. The Triglyceride-to-HDL Cholesterol Ratio — pmc.ncbi.nlm.nih.gov ↗
  18. Association between the TyG index and TG/HDL-C ratio as insulin resistance markers and the risk of colorectal cancer — bmccancer.biomedcentral.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→